| 1781 |
LUCIRES |
RESMETIROM 100 MG |
TABLET |
BOTTLE |
IN CONJUNCTION WITH DIET AND EXCERCISE FOR THE TREATMENT OF ADULT WITH NONCIRRHOTIC STEATOHEPATITIS WITH MODERATE TO ADVANCED LIVER FIBROSIS |
NULL |
LUCIUS PHARMACEUTICALS(LAO) CO.,LTD |
LUCIUS PHARMACEUTICALS(LAO) CO.,LTD |
LAOS |
CERTIFICATE RELEASED |
09 L 1196/24 |
24-SEP-2024 |
23-SEP-2029 |
View |
| 1782 |
LUCIRIBO |
RIBOCICLIB 200 MG |
TABLET |
BOTTLE |
FOR THE TREATMENT OF ADULT PATIENTS WITH HORMONE RECEPTOR POSITIVE, HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR 2 NEGATIVE ADVANCED OR METASTATIC BREAST CANCER |
NULL |
LUCIUS PHARMACEUTICALS(LAO) CO.,LTD |
LUCIUS PHARMACEUTICALS(LAO) CO.,LTD |
LAOS |
CERTIFICATE RELEASED |
09 L 1191/24 |
24-SEP-2024 |
23-SEP-2029 |
View |
| 1783 |
LUCIRIP |
RIPRETINIB 50 MG |
TABLET |
BOTTLE |
FOR THE TREATMENT OF ADULT PATIENTS WITH ADVANCED GASTROINTESTINAL STROMAL TUMOR WHO HAVE RECEIVED PRIOR TREATMENT WITH 3 OR MORE KINASE INHIBITORS, INCLUDING IMATINIB |
NULL |
LUCIUS PHARMACEUTICALS(LAO) CO.,LTD |
LUCIUS PHARMACEUTICALS(LAO) CO.,LTD |
LAOS |
CERTIFICATE RELEASED |
06 L 1356/25 |
17-JUN-2025 |
16-JUN-2030 |
View |
| 1784 |
LUCIRIT |
RITLECITINIB 50 MG |
CAPSULE |
BOTTLE |
TREATMENT OF SEVERE ALOPECIA AREATA IN ADULTS AND ADOLESCENTS 12 YEARS AND OLDERS |
NULL |
LUCIUS PHARMACEUTICALS(LAO) CO.,LTD |
LUCIUS PHARMACEUTICALS(LAO) CO.,LTD |
LAOS |
CERTIFICATE RELEASED |
10 L 1035/23 |
30-OCT-2023 |
29-OCT-2026 |
View |
| 1785 |
LUCIRUX |
RUXOLITINIB 20 MG |
TABLET |
BOTTLE |
FOR THE TREATMENT OF INTERMEDIATE OR HIGH RISK MYELOFIBROSIS, INCLUDING PRIMARY MYELOFIBROSIS, POST-POLYCYTHEMIA VERA MYELOFIBROSIS AND POST-ESSENTIAL THROMBOCYTHEMIA MYELOFIBROSIS |
NULL |
LUCIUS PHARMACEUTICALS(LAO) CO.,LTD |
LUCIUS PHARMACEUTICALS(LAO) CO.,LTD |
LAOS |
CERTIFICATE RELEASED |
03 L 1313/25 |
07-APR-2025 |
06-APR-2030 |
View |
| 1786 |
LUCIRUX |
RUXOLITINIB 5 MG |
TABLET |
BOTTLE |
FOR THE TREATMENT OF INTERMEDIATE OR HIGH RISK MYELOFIBROSIS, INCLUDING PRIMARY MYELOFIBROSIS, POST-POLYCYTHEMIA VERA MYELOFIBROSIS AND POST-ESSENTIAL THROMBOCYTHEMIA MYELOFIBROSIS |
NULL |
LUCIUS PHARMACEUTICALS(LAO) CO.,LTD |
LUCIUS PHARMACEUTICALS(LAO) CO.,LTD |
LAOS |
CERTIFICATE RELEASED |
03 L 1323/25 |
07-APR-2025 |
06-APR-2030 |
View |
| 1787 |
LUCISEL |
SELPERCATINIB 40 MG |
CAPSULE |
BOTTLE |
TREATMENT OF NON SMALL CELL LUNG CANCER |
NULL |
LUCIUS PHARMACEUTICALS(LAO) CO.,LTD |
LUCIUS PHARMACEUTICALS(LAO) CO.,LTD |
LAOS |
CERTIFICATE RELEASED |
09 L 1008/23 |
20-SEP-2023 |
19-SEP-2026 |
View |
| 1788 |
LUCISELADE |
SELADELPAR 10 MG |
CAPSULE |
BOTTLE |
FOR THE TREATMENT OF PRIMARY BILIARY CHOLANGITIS IN COMBINATION WITH URSODEOXYCHOLIC ACID IN ADULT WHO HAVE AN INADEQUATE RESPONSE TO UDCA OR AS MONOTHERAPY IN PATIENTS UNABLE TO TOLERATE UDCA |
NULL |
LUCIUS PHARMACEUTICALS(LAO) CO.,LTD |
LUCIUS PHARMACEUTICALS(LAO) CO.,LTD |
LAOS |
CERTIFICATE RELEASED |
04 L 1341/25 |
2025-04-21 |
2030-04-20 |
View |
| 1789 |
LUCISELIN |
SELINEXOR 20 MG |
TABLET |
BLISTERPACK |
IN COMBINATION WITH BOREZOMIB AND DEXAMETHASONE FOR THE TREATMENT OF ADULT PATIENTS WITH MULTIPLE MYELOMA WHO HAVE RECEIVED AT LEAST ONE PRIOR THERAPY |
NULL |
LUCIUS PHARMACEUTICALS(LAO) CO.,LTD |
LUCIUS PHARMACEUTICALS(LAO) CO.,LTD |
LAOS |
CERTIFICATE RELEASED |
10 L 1027/23 |
10-OCT-2023 |
09-OCT-2026 |
View |
| 1790 |
LUCISELUME |
SELUMETINIB 10 MG |
CAPSULE |
BOTTLE |
FOR THE TREATMENT OF PEDIATRIC PATIENTS 2 YEARS OF AGE AND OLDER WITH NEUROFIBROMATOSIS TYPE 1 WHO HAVE SYMTOMATIC, INOPERABLE PLEXIFORM NEUROFIBROMAS |
NULL |
LUCIUS PHARMACEUTICALS(LAO) CO.,LTD |
LUCIUS PHARMACEUTICALS(LAO) CO.,LTD |
LAOS |
CERTIFICATE RELEASED |
03 L 1074/24 |
14-MAR-2023 |
13-MAR-2027 |
View |
